Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP)Ahmet M. Ulusan, Roderick H. Dashwood|Cancer Prevention Research|2020Cited by 18